Journal Article (Erratum/Correction)

DKFZ-2025-00409

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Corrigendum to 'Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group': [Ann Oncol 35 (2024) 588-606].

Mosele, M. F. ; Westphalen, C. B. ; Stenzinger, A. ; Barlesi, F. ; Bayle, A. ; Bièche, I. ; Bonastre, J. ; Castro, E. ; Dienstmann, R. ; Krämer, A.DKFZ* ; Czarnecka, A. M. ; Meric-Bernstam, F. ; Michiels, S. ; Miller, R. ; Normanno, N. ; Reis-Filho, J. ; Remon, J. ; Robson, M. ; Rouleau, E. ; Scarpa, A. ; Serrano, C. ; Mateo, J. ; André, F.

2025
Elsevier Amsterdam [u.a.]

This record in other databases:

Please use a persistent id in citations: doi:10.1016/j.annonc.2024.11.010

Note: Volume 36, Issue 4, April 2025, Page 472

---

Contributing Institute(s):

1. KKE Mol. Hämatologie/Onkologie (A360)

Research Program(s):

1. 311 - Zellbiologie und Tumorbiologie (POF4-311) (POF4-311)

Appears in the scientific report 2025

---

Database coverage:
; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 50 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---